Clinical Trial: Diabetic Neuropathic Pain: A Multi-Omics Study on Gut-Serum Microbiome and Metabolome Characteristics and Their Correlation with Disease Progression (China)

Posted On: 2026-11-06

China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diabetic Neuropathic Pain: A Multi-Omics Study on Gut-Serum Microbiome and Metabolome Characteristics and Their Correlation with Disease Progression'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136132

Registration Time: 2026/11/05

Type: Observational study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=317884

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Diabetic Neuropathic Pain: A Multi-Omics Study on Gut-Serum Microbiome and Metabolome Characteristics and Their Correlation with Disease Progression (China)